Apellis Pharmaceuticals Inc (APLS) — Free Cash Flow Generation Index
Apellis Pharmaceuticals Inc (APLS) has a Free Cash Flow Generation Index of 1.00x as of September 2025. Free cash flow of $108.32 Million represents 1% of operating cash flow ($108.47 Million). Explore Apellis Pharmaceuticals Inc capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Apellis Pharmaceuticals Inc Free Cash Flow Generation Index (2025–2025)
Historical FCF Generation Index trend for Apellis Pharmaceuticals Inc across 1 annual periods. For the full cash flow conversion analysis, see APLS cash flow conversion.
Annual Free Cash Flow Generation for Apellis Pharmaceuticals Inc (2025–2025)
Year-by-year Free Cash Flow Generation Index for Apellis Pharmaceuticals Inc. Check APLS total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.99x | $45.01 Million | $45.33 Million | $313.00K | — |